Search results
Results from the WOW.Com Content Network
Global Invacom Group Limited: Singapore: SG2E91982768: 21 June 2012 Global Investments Limited: Bermuda: SGXC73602341: 20 December 2006 Global Palm Resources Holdings Limited: Singapore: SG1CD3000003: 29 April 2010 Global Testing Corporation Limited: Singapore: SG1BB4000008: 24 August 2005 Golden Agri-Resources Ltd: Others: MU0117U00026: 9 July ...
The company also acquired, later in the same year, Meritage Pharma for $245 million, Foresight Biotherapeutics for $300 million [24] and Dyax for $6.5 billion. [ 25 ] [ 26 ] The purchases bolstered Shires gastro-intestinal and rare disease sectors, with Phase-III-ready treatment - Budesonide - for the treatment of eosinophilic esophagitis .
Mundipharma International Limited is a British multinational research-based pharmaceutical company owned by members of the Sackler family with locations in United Kingdom, Canada, Germany, and Singapore. [2] In Germany, Mundipharma is a subsidiary of Mundipharma International Limited and Mundipharma AG.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
SGX was formed on 1 December 1999 as a holding company. The share capital of some former exchange companies, namely Stock Exchange of Singapore (SES), Singapore International Monetary Exchange (SIMEX) that was founded in 1984 and Securities Clearing and Computer Services Pte Ltd (SCCS) were cancelled and new shares issued in these companies were fully paid up by SGX.
With the lower re-negotiated a lower price of $21.5 billion between Johnson & Johnson and Guidant, Boston Scientific announced an unsolicited offer of $24.6 billion for Guidant (an offer of $72 per share of Guidant, $36 in cash and a fixed number of Boston Scientific shares valued at $36 a share). 26 2006 Johnson & Johnson: Guidant: 24.2 38
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland.Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.